Position in INVA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,273,650
+$912,831 QoQ
Shares Held
140,500
+19.0% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. INVA ranks #69 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,600 | $332,493,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
303,140 | $234,218,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
387,720 | $128,284,916 | |
| 4 | INSM |
INSMED Inc
|
625,912 | $102,349,130 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,191,100 | $57,137,067 | |
| 6 | INCY |
Incyte Corp
|
489,774 | $46,097,528 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
425,431 | $41,373,164 | |
| 8 | MRNA |
Moderna, Inc.
|
696,100 | $35,361,880 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,273,650 | 140,500 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,360,819 | 118,100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,109,700 | 115,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,288,251 | 113,900 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,990,674 | 109,800 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,905,030 | 109,800 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,120,238 | 109,800 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,835,160 | 111,900 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,734,312 | 113,800 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,851,016 | 115,400 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,683,504 | 129,600 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,699,455 | 133,500 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,525,500 | 135,600 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,007,375 | 151,500 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,717,119 | 147,900 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,183,004 | 147,900 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,861,865 | 147,900 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,375,325 | 137,700 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,427,963 | 145,300 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,948,473 | 145,300 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,784,135 | 149,300 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,849,827 | 149,300 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,560,185 | 149,300 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,055,060 | 147,000 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,617,000 | 137,500 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||